• レポートコード:MRC2Q12-00670 • 出版社/出版日:QYResearch / 2022年12月 • レポート形態:英文、PDF、114ページ • 納品方法:Eメール(納期:3営業日) • 産業分類:化学&材料 |
Single User | ¥735,000 (USD4,900) | ▷ お問い合わせ |
Enterprise License | ¥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、1-ペンタデカノールのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 1-ペンタデカノールのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 1-ペンタデカノールの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 1-ペンタデカノールのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの1-ペンタデカノールの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の1-ペンタデカノールの売上および2028年までの予測に焦点を当てています。 1-ペンタデカノールのグローバル主要企業には、TCI、Alfa Aesar、Apollo Scientific、Dr. Ehrenstorfer、TRC、TargetMol、Biosynth、Spectrum Chemical、Kanto、Eurolabs、Acros Organics、AccuStandardなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。 1-ペンタデカノール市場は、タイプとアプリケーションによって区分されます。世界の1-ペンタデカノール市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 純度99%以上、純度98%~99%、純度95%~98%、純度95%以下 【アプリケーション別セグメント】 研究所、工場 【掲載地域】 北米:アメリカ、カナダ ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米:メキシコ、ブラジル、アルゼンチン 中東・アフリカ:トルコ、サウジアラビア、UAE 【目次(一部)】 ・調査の範囲 - 1-ペンタデカノール製品概要 - タイプ別市場(純度99%以上、純度98%~99%、純度95%~98%、純度95%以下) - アプリケーション別市場(研究所、工場) - 調査の目的 ・エグゼクティブサマリー - 世界の1-ペンタデカノール販売量予測2017-2028 - 世界の1-ペンタデカノール売上予測2017-2028 - 1-ペンタデカノールの地域別販売量 - 1-ペンタデカノールの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別1-ペンタデカノール販売量 - 主要メーカー別1-ペンタデカノール売上 - 主要メーカー別1-ペンタデカノール価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模(純度99%以上、純度98%~99%、純度95%~98%、純度95%以下) - 1-ペンタデカノールのタイプ別販売量 - 1-ペンタデカノールのタイプ別売上 - 1-ペンタデカノールのタイプ別価格 ・アプリケーション別市場規模(研究所、工場) - 1-ペンタデカノールのアプリケーション別販売量 - 1-ペンタデカノールのアプリケーション別売上 - 1-ペンタデカノールのアプリケーション別価格 ・北米市場 - 北米の1-ペンタデカノール市場規模(タイプ別、アプリケーション別) - 主要国別の1-ペンタデカノール市場規模(アメリカ、カナダ) ・ヨーロッパ市場 - ヨーロッパの1-ペンタデカノール市場規模(タイプ別、アプリケーション別) - 主要国別の1-ペンタデカノール市場規模(ドイツ、フランス、イギリス、イタリア、ロシア) ・アジア太平洋市場 - アジア太平洋の1-ペンタデカノール市場規模(タイプ別、アプリケーション別) - 主要国別の1-ペンタデカノール市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア) ・中南米市場 - 中南米の1-ペンタデカノール市場規模(タイプ別、アプリケーション別) - 主要国別の1-ペンタデカノール市場規模(メキシコ、ブラジル、アルゼンチン) ・中東・アフリカ市場 - 中東・アフリカの1-ペンタデカノール市場規模(タイプ別、アプリケーション別) - 主要国別の1-ペンタデカノール市場規模(トルコ、サウジアラビア) ・企業情報 TCI、Alfa Aesar、Apollo Scientific、Dr. Ehrenstorfer、TRC、TargetMol、Biosynth、Spectrum Chemical、Kanto、Eurolabs、Acros Organics、AccuStandard ・産業チェーン及び販売チャネル分析 - 1-ペンタデカノールの産業チェーン分析 - 1-ペンタデカノールの原材料 - 1-ペンタデカノールの生産プロセス - 1-ペンタデカノールの販売及びマーケティング - 1-ペンタデカノールの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 1-ペンタデカノールの産業動向 - 1-ペンタデカノールのマーケットドライバー - 1-ペンタデカノールの課題 - 1-ペンタデカノールの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for 1-Pentadecanol estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for 1-Pentadecanol is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for 1-Pentadecanol is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for 1-Pentadecanol is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of 1-Pentadecanol include TCI, Alfa Aesar, Apollo Scientific, Dr. Ehrenstorfer, TRC, TargetMol, Biosynth, Spectrum Chemical and Kanto, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the 1-Pentadecanol production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of 1-Pentadecanol by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the 1-Pentadecanol manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional 1-Pentadecanol market. Further, it explains the major drivers and regional dynamics of the global 1-Pentadecanol market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
TCI
Alfa Aesar
Apollo Scientific
Dr. Ehrenstorfer
TRC
TargetMol
Biosynth
Spectrum Chemical
Kanto
Eurolabs
Acros Organics
AccuStandard
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
1-Pentadecanol Segment by Type
Purity of 99% and Above
Purity Between 98%-99%
Purity Between 95%-98%
Purity Below 95%
1-Pentadecanol Segment by Application
Laboratory
Factory
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the 1-Pentadecanol production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the 1-Pentadecanol market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for 1-Pentadecanol, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of 1-Pentadecanol, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for 1-Pentadecanol, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the 1-Pentadecanol sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global 1-Pentadecanol market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for 1-Pentadecanol sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including TCI, Alfa Aesar, Apollo Scientific, Dr. Ehrenstorfer, TRC, TargetMol, Biosynth, Spectrum Chemical and Kanto, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: 1-Pentadecanol capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of 1-Pentadecanol in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of 1-Pentadecanol manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, 1-Pentadecanol sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 1-Pentadecanol Product Introduction
1.2 Market by Type
1.2.1 Global 1-Pentadecanol Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity of 99% and Above
1.2.3 Purity Between 98%-99%
1.2.4 Purity Between 95%-98%
1.2.5 Purity Below 95%
1.3 Market by Application
1.3.1 Global 1-Pentadecanol Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Laboratory
1.3.3 Factory
1.4 Study Objectives
1.5 Years Considered
2 Global 1-Pentadecanol Production
2.1 Global 1-Pentadecanol Production Capacity (2017-2028)
2.2 Global 1-Pentadecanol Production by Region: 2017 VS 2021 VS 2028
2.3 Global 1-Pentadecanol Production by Region
2.3.1 Global 1-Pentadecanol Historic Production by Region (2017-2022)
2.3.2 Global 1-Pentadecanol Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global 1-Pentadecanol Sales in Volume & Value Estimates and Forecasts
3.1 Global 1-Pentadecanol Sales Estimates and Forecasts 2017-2028
3.2 Global 1-Pentadecanol Revenue Estimates and Forecasts 2017-2028
3.3 Global 1-Pentadecanol Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global 1-Pentadecanol Sales by Region
3.4.1 Global 1-Pentadecanol Sales by Region (2017-2022)
3.4.2 Global Sales 1-Pentadecanol by Region (2023-2028)
3.5 Global 1-Pentadecanol Revenue by Region
3.5.1 Global 1-Pentadecanol Revenue by Region (2017-2022)
3.5.2 Global 1-Pentadecanol Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global 1-Pentadecanol Production Capacity by Manufacturers
4.2 Global 1-Pentadecanol Sales by Manufacturers
4.2.1 Global 1-Pentadecanol Sales by Manufacturers (2017-2022)
4.2.2 Global 1-Pentadecanol Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of 1-Pentadecanol in 2021
4.3 Global 1-Pentadecanol Revenue by Manufacturers
4.3.1 Global 1-Pentadecanol Revenue by Manufacturers (2017-2022)
4.3.2 Global 1-Pentadecanol Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by 1-Pentadecanol Revenue in 2021
4.4 Global 1-Pentadecanol Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global 1-Pentadecanol Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global 1-Pentadecanol Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global 1-Pentadecanol Sales by Type
5.1.1 Global 1-Pentadecanol Historical Sales by Type (2017-2022)
5.1.2 Global 1-Pentadecanol Forecasted Sales by Type (2023-2028)
5.1.3 Global 1-Pentadecanol Sales Market Share by Type (2017-2028)
5.2 Global 1-Pentadecanol Revenue by Type
5.2.1 Global 1-Pentadecanol Historical Revenue by Type (2017-2022)
5.2.2 Global 1-Pentadecanol Forecasted Revenue by Type (2023-2028)
5.2.3 Global 1-Pentadecanol Revenue Market Share by Type (2017-2028)
5.3 Global 1-Pentadecanol Price by Type
5.3.1 Global 1-Pentadecanol Price by Type (2017-2022)
5.3.2 Global 1-Pentadecanol Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global 1-Pentadecanol Sales by Application
6.1.1 Global 1-Pentadecanol Historical Sales by Application (2017-2022)
6.1.2 Global 1-Pentadecanol Forecasted Sales by Application (2023-2028)
6.1.3 Global 1-Pentadecanol Sales Market Share by Application (2017-2028)
6.2 Global 1-Pentadecanol Revenue by Application
6.2.1 Global 1-Pentadecanol Historical Revenue by Application (2017-2022)
6.2.2 Global 1-Pentadecanol Forecasted Revenue by Application (2023-2028)
6.2.3 Global 1-Pentadecanol Revenue Market Share by Application (2017-2028)
6.3 Global 1-Pentadecanol Price by Application
6.3.1 Global 1-Pentadecanol Price by Application (2017-2022)
6.3.2 Global 1-Pentadecanol Price Forecast by Application (2023-2028)
7 North America
7.1 North America 1-Pentadecanol Market Size by Type
7.1.1 North America 1-Pentadecanol Sales by Type (2017-2028)
7.1.2 North America 1-Pentadecanol Revenue by Type (2017-2028)
7.2 North America 1-Pentadecanol Market Size by Application
7.2.1 North America 1-Pentadecanol Sales by Application (2017-2028)
7.2.2 North America 1-Pentadecanol Revenue by Application (2017-2028)
7.3 North America 1-Pentadecanol Sales by Country
7.3.1 North America 1-Pentadecanol Sales by Country (2017-2028)
7.3.2 North America 1-Pentadecanol Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe 1-Pentadecanol Market Size by Type
8.1.1 Europe 1-Pentadecanol Sales by Type (2017-2028)
8.1.2 Europe 1-Pentadecanol Revenue by Type (2017-2028)
8.2 Europe 1-Pentadecanol Market Size by Application
8.2.1 Europe 1-Pentadecanol Sales by Application (2017-2028)
8.2.2 Europe 1-Pentadecanol Revenue by Application (2017-2028)
8.3 Europe 1-Pentadecanol Sales by Country
8.3.1 Europe 1-Pentadecanol Sales by Country (2017-2028)
8.3.2 Europe 1-Pentadecanol Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific 1-Pentadecanol Market Size by Type
9.1.1 Asia Pacific 1-Pentadecanol Sales by Type (2017-2028)
9.1.2 Asia Pacific 1-Pentadecanol Revenue by Type (2017-2028)
9.2 Asia Pacific 1-Pentadecanol Market Size by Application
9.2.1 Asia Pacific 1-Pentadecanol Sales by Application (2017-2028)
9.2.2 Asia Pacific 1-Pentadecanol Revenue by Application (2017-2028)
9.3 Asia Pacific 1-Pentadecanol Sales by Region
9.3.1 Asia Pacific 1-Pentadecanol Sales by Region (2017-2028)
9.3.2 Asia Pacific 1-Pentadecanol Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America 1-Pentadecanol Market Size by Type
10.1.1 Latin America 1-Pentadecanol Sales by Type (2017-2028)
10.1.2 Latin America 1-Pentadecanol Revenue by Type (2017-2028)
10.2 Latin America 1-Pentadecanol Market Size by Application
10.2.1 Latin America 1-Pentadecanol Sales by Application (2017-2028)
10.2.2 Latin America 1-Pentadecanol Revenue by Application (2017-2028)
10.3 Latin America 1-Pentadecanol Sales by Country
10.3.1 Latin America 1-Pentadecanol Sales by Country (2017-2028)
10.3.2 Latin America 1-Pentadecanol Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa 1-Pentadecanol Market Size by Type
11.1.1 Middle East and Africa 1-Pentadecanol Sales by Type (2017-2028)
11.1.2 Middle East and Africa 1-Pentadecanol Revenue by Type (2017-2028)
11.2 Middle East and Africa 1-Pentadecanol Market Size by Application
11.2.1 Middle East and Africa 1-Pentadecanol Sales by Application (2017-2028)
11.2.2 Middle East and Africa 1-Pentadecanol Revenue by Application (2017-2028)
11.3 Middle East and Africa 1-Pentadecanol Sales by Country
11.3.1 Middle East and Africa 1-Pentadecanol Sales by Country (2017-2028)
11.3.2 Middle East and Africa 1-Pentadecanol Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 TCI
12.1.1 TCI Corporation Information
12.1.2 TCI Overview
12.1.3 TCI 1-Pentadecanol Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 TCI 1-Pentadecanol Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 TCI Recent Developments
12.2 Alfa Aesar
12.2.1 Alfa Aesar Corporation Information
12.2.2 Alfa Aesar Overview
12.2.3 Alfa Aesar 1-Pentadecanol Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Alfa Aesar 1-Pentadecanol Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Alfa Aesar Recent Developments
12.3 Apollo Scientific
12.3.1 Apollo Scientific Corporation Information
12.3.2 Apollo Scientific Overview
12.3.3 Apollo Scientific 1-Pentadecanol Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Apollo Scientific 1-Pentadecanol Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Apollo Scientific Recent Developments
12.4 Dr. Ehrenstorfer
12.4.1 Dr. Ehrenstorfer Corporation Information
12.4.2 Dr. Ehrenstorfer Overview
12.4.3 Dr. Ehrenstorfer 1-Pentadecanol Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Dr. Ehrenstorfer 1-Pentadecanol Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Dr. Ehrenstorfer Recent Developments
12.5 TRC
12.5.1 TRC Corporation Information
12.5.2 TRC Overview
12.5.3 TRC 1-Pentadecanol Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 TRC 1-Pentadecanol Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 TRC Recent Developments
12.6 TargetMol
12.6.1 TargetMol Corporation Information
12.6.2 TargetMol Overview
12.6.3 TargetMol 1-Pentadecanol Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 TargetMol 1-Pentadecanol Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 TargetMol Recent Developments
12.7 Biosynth
12.7.1 Biosynth Corporation Information
12.7.2 Biosynth Overview
12.7.3 Biosynth 1-Pentadecanol Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Biosynth 1-Pentadecanol Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Biosynth Recent Developments
12.8 Spectrum Chemical
12.8.1 Spectrum Chemical Corporation Information
12.8.2 Spectrum Chemical Overview
12.8.3 Spectrum Chemical 1-Pentadecanol Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Spectrum Chemical 1-Pentadecanol Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Spectrum Chemical Recent Developments
12.9 Kanto
12.9.1 Kanto Corporation Information
12.9.2 Kanto Overview
12.9.3 Kanto 1-Pentadecanol Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Kanto 1-Pentadecanol Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Kanto Recent Developments
12.10 Eurolabs
12.10.1 Eurolabs Corporation Information
12.10.2 Eurolabs Overview
12.10.3 Eurolabs 1-Pentadecanol Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Eurolabs 1-Pentadecanol Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Eurolabs Recent Developments
12.11 Acros Organics
12.11.1 Acros Organics Corporation Information
12.11.2 Acros Organics Overview
12.11.3 Acros Organics 1-Pentadecanol Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Acros Organics 1-Pentadecanol Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Acros Organics Recent Developments
12.12 AccuStandard
12.12.1 AccuStandard Corporation Information
12.12.2 AccuStandard Overview
12.12.3 AccuStandard 1-Pentadecanol Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 AccuStandard 1-Pentadecanol Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 AccuStandard Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 1-Pentadecanol Industry Chain Analysis
13.2 1-Pentadecanol Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 1-Pentadecanol Production Mode & Process
13.4 1-Pentadecanol Sales and Marketing
13.4.1 1-Pentadecanol Sales Channels
13.4.2 1-Pentadecanol Distributors
13.5 1-Pentadecanol Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 1-Pentadecanol Industry Trends
14.2 1-Pentadecanol Market Drivers
14.3 1-Pentadecanol Market Challenges
14.4 1-Pentadecanol Market Restraints
15 Key Finding in The Global 1-Pentadecanol Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer